Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) shares were down 0.8% during mid-day trading on Wednesday. The company traded as low as $3.60 and last traded at $3.92. Approximately 38,933 shares were traded during mid-day trading, a decline of 35% from the average daily volume of 59,724 shares. The stock had previously closed at $3.95.
Alpha Tau Medical Trading Up 10.1%
The firm’s 50-day moving average price is $3.85 and its two-hundred day moving average price is $2.67.
Alpha Tau Medical Company Profile
Alpha Tau Medical Ltd. is an Israeli medical-device company focused on developing cancer treatments based on targeted alpha radiation. Its lead technology, Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy), is designed to deliver localized alpha radiation directly into solid tumors while limiting exposure to surrounding healthy tissue.
Alpha DaRT uses implantable sources containing radium-224. As the material decays, it generates short-range alpha particles intended to damage tumor cells.
Recommended Stories
- Five stocks we like better than Alpha Tau Medical
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
